Clinical Observation of Icotinib Hydrochloride in First-line Therapy 
for Pulmonary Adenocarcinoma

Clinical Observation of Icotinib Hydrochloride in First-line Therapy 
for Pulmonary Adenocarcinoma

Background and objective It has been proven that icotinib hydrochloride, as a molecule targeted drug, can be safely and efficiently used to treat advanced non-small cell lung cancer (NSCLC) for second-line or third-line. This research was aimed to investigate the efficacy and toxicity of icotinib hy...

Full description

Bibliographic Details
Main Authors: Xinjie YANG, Hui ZHANG, Na QIN, Xi LI, Jingying NONG, Jialin LV, Yuhua WU, Quan ZHANG, Shucai ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-07-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Icotinib hydrochloride
First-line therapy
Adenocarcinoma
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2013.07.06

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2013.07.06

Similar Items